Baylor College of Medicine

Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome (H-51783)



Clinical Study for Patients with Dry Eye Associated with Sjögren’s Disease:

If you are an adult with dry eye disease associated with Sjögren’s, you may be eligible to take part in a clinical research study being conducted by Sylentis S.A.U.

The purpose is to compare the study eye drop to placebo (eyedrop without medication) in treating the signs and symptoms of dry eye associated with Sjögren’s.

You may be eligible to take part in the SYL1001_V Study if:

  • You are 18 years or older
  • You have a diagnosis of Sjögren’s
  • Other entry criteria apply and your eligibility will be determined by the study staff
  • If you decide to take part in the study, your participation could last approximately 3.5 months and consist of 5 to 6 visits to the study center. You will be reimbursed for each completed visit.

IRB: H-51783




Back to topback-to-top